Medtronic also announced it has entered a global partnership with Abbott in an effort to expand CGM device options for patients living with diabetes. The FDA approved a new disposable continuous glucose monitor (CGM) from medical device company Medtronic, according to a release.1 The Simplera is...
On March 5, 2024, the US Food and Drug Administration (FDA) granted clearance to market the first over-the-counter (OTC) continuous glucose monitor (CGM). Dexcom’s Stelo Glucose Biosensor System (Stelo) is an integrated CGM (iCGM) designed for individuals 18 years and older who do not ...
The new Libre is now an "integrated CGM," meaning that it is authorized to be interoperable with other compatible diabetes devices or interfaces, says its manufacturer, Abbott. Also new in Libre 2 is the pediatric indication — the previous one was approved for adults only — and better accur...
The U.S. Food and Drug Administration on Tuesday approved the country's first over-the-counter continuous glucose monitor for type 2 diabetes. The new Dexcom Stelo Glucose Biosensor System, which will be available by summer, is intended for people 18 and older who have type 2 diabetes but d...
The U.S. Food and Drug Administration on Tuesday approved the country's first over-the-counter continuous glucose monitor for type 2 diabetes. Ad The new Dexcom Stelo Glucose Biosensor System, which will be available by summer, is intended for people 18 and older who have type 2 diabetes bu...